Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Human galectin-2: nuclear presence in vitro and its modulation by quiescence/stress factors

B Dvorankova, L Lacina, K Jr Smetana, M Lensch, JC Manning, S Andre, HJ Gabius

. 2008 ; 23 (2) : 167-178.

Jazyk angličtina Země Španělsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10026229
E-zdroje

NLK Open Journal Systems (OJS) od 2002

Galectins have the particular capacity to interact with distinct proteins, in addition to the typical reactivity of lectins with glycans. Therefore, they can be functionally active when residing at places other than the membrane or extracellular matrix. In fact, nuclear presence of galectins-1 and -3 is solidly documented but it is an open question whether these two cases are exceptional within this lectin family. Thus, galectin-2, which shares 43% sequence identity on the protein level with galectin-1, warrants study in this respect. Based on initial immunohistochemical evidence we herein address the issue as to whether this galectin can join the category of nuclear lectins. To do so we studied different types of cell in vitro using an antibody preparation free of cross-reactivity against other tested galectins. The immunocytochemical experiments revealed that galectin-2 was present in nuclei of murine 3T3 fibroblasts and also genetically engineered human colon carcinoma cells with stable ectopic expression. Transport of galectin-2 to the nucleus could be enhanced by physical (UV light), chemical (mitomycin C, serum withdrawal) or cell biological (coculture with stromal cells) treatment modalities. As a means of further characterizing the staining profile cytochemically, a series of markers with well-defined site of residency within the nuclear compartment was tested in parallel. Importantly, no colocalization with galectins-1 and -3 and the splicing factor SC35 was detectable, the former cases also serving as inherent specificity control. In contrast, a similarity was uncovered in the case of the promyelocytic leukemia (PML) protein as marker of PML nuclear bodies. In aggregate, nuclear localization is documented for galectin-2. This attribute should thus not be considered as an exceptional finding confined to galectins-1 and -3. That even closely related family members, here galectins-1 and -2, exhibit distinct intranuclear localization patterns gives ensuing research a clear direction.

000      
00000naa 2200000 a 4500
001      
bmc10026229
003      
CZ-PrNML
005      
20111210192257.0
008      
101018s2008 sp e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sp
100    1_
$a Dvořánková, Barbora, $d 1955- $7 xx0076196
245    10
$a Human galectin-2: nuclear presence in vitro and its modulation by quiescence/stress factors / $c B Dvorankova, L Lacina, K Jr Smetana, M Lensch, JC Manning, S Andre, HJ Gabius
314    __
$a Charles University, 1st Faculty of Medicine, Institute of Anatomy, Prague, Czech Republic.
520    9_
$a Galectins have the particular capacity to interact with distinct proteins, in addition to the typical reactivity of lectins with glycans. Therefore, they can be functionally active when residing at places other than the membrane or extracellular matrix. In fact, nuclear presence of galectins-1 and -3 is solidly documented but it is an open question whether these two cases are exceptional within this lectin family. Thus, galectin-2, which shares 43% sequence identity on the protein level with galectin-1, warrants study in this respect. Based on initial immunohistochemical evidence we herein address the issue as to whether this galectin can join the category of nuclear lectins. To do so we studied different types of cell in vitro using an antibody preparation free of cross-reactivity against other tested galectins. The immunocytochemical experiments revealed that galectin-2 was present in nuclei of murine 3T3 fibroblasts and also genetically engineered human colon carcinoma cells with stable ectopic expression. Transport of galectin-2 to the nucleus could be enhanced by physical (UV light), chemical (mitomycin C, serum withdrawal) or cell biological (coculture with stromal cells) treatment modalities. As a means of further characterizing the staining profile cytochemically, a series of markers with well-defined site of residency within the nuclear compartment was tested in parallel. Importantly, no colocalization with galectins-1 and -3 and the splicing factor SC35 was detectable, the former cases also serving as inherent specificity control. In contrast, a similarity was uncovered in the case of the promyelocytic leukemia (PML) protein as marker of PML nuclear bodies. In aggregate, nuclear localization is documented for galectin-2. This attribute should thus not be considered as an exceptional finding confined to galectins-1 and -3. That even closely related family members, here galectins-1 and -2, exhibit distinct intranuclear localization patterns gives ensuing research a clear direction.
650    _2
$a buňky 3T3 $7 D016475
650    _2
$a adenokarcinom $x metabolismus $7 D000230
650    _2
$a zvířata $7 D000818
650    _2
$a biologické markery $7 D015415
650    _2
$a biologický transport $7 D001692
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčné jádro $x metabolismus $7 D002467
650    _2
$a kokultivační techniky $7 D018920
650    _2
$a nádory tračníku $x metabolismus $7 D003110
650    _2
$a kultivační média bez séra $7 D016895
650    _2
$a galektin 2 $x metabolismus $7 D037501
650    _2
$a imunohistochemie $7 D007150
650    _2
$a myši $7 D051379
650    _2
$a mitomycin $x farmakologie $7 D016685
650    _2
$a ultrafialové záření $7 D014466
650    _2
$a lidé $7 D006801
650    _2
$a financování organizované $7 D005381
700    1_
$a Lacina, Lukáš, $d 1979- $7 xx0106429
700    1_
$a Lensch, M.
700    1_
$a Smetana, Karel, $d 1958- $7 jn20000710554
700    1_
$a Manning, J. C.
700    1_
$a André, Sabine, $d 1966- $7 jn19990000189
700    1_
$a Gabius, H. J.
773    0_
$w MED00005439 $t Histology and histopathology $g Roč. 23, č. 2 (2008), s. 167-178 $x 0213-3911
910    __
$a ABA008 $b x $y 7
990    __
$a 20101022105432 $b ABA008
991    __
$a 20101022105821 $b ABA008
999    __
$a ok $b bmc $g 801334 $s 666077
BAS    __
$a 3
BMC    __
$a 2008 $b 23 $c 2 $d 167-178 $m Histology and histopathology $n Histol Histopathol $x MED00005439
LZP    __
$a 2010-B/jtme

Najít záznam